Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Thursday September 26.
Gilead (NASDAQ:GILD), Regeneron (NASDAQ:REGN), Biogen Idec (NASDAQ:BIIB), Celgene (NASDAQ:CELG), Facebook (NASDAQ:FB), Netflix (NASDAQ:NFLX), Amazon (NASDAQ:AMZN), Priceline (NASDAQ:PCLN), Tesla (NASDAQ:TSLA), LinkedIn (NYSE:LNKD)
At the end of the year, money managers want to beef up clients' portfolios with winning stocks. Cramer outlined 10 stocks that money managers will be buying from now until the end of the year: Gilead (GILD), Regeneron (REGN), Biogen Idec (BIIB), Celgene (CELG), Facebook (FB), Netflix (NFLX), Amazon (AMZN), Priceline (PCLN), Tesla (TSLA), LinkedIn (LNKD)
Foundation (NASDAQ:FMI), Acceleron (NASDAQ:XLRN), Premier (NASDAQ:PINC), Rocket Fuel (NASDAQ:FUEL), Benefitfocus (NASDAQ:BNFT), FireEye (NASDAQ:FEYE), Potbelly Sandwich Works (NASDAQ:PBPB), Veracyte (NASDAQ:VCYT), Critero (NASDAQ:CRTO), Veeva (NYSE:VEEV), Chegg (NYSE:CHGG), Voxeljet (NYSE:VJET), CommScope (NASDAQ:COMM). Other stock mentioned: Coty (NYSE:COTY)
2013 has been incredible year for IPOs. So far, there have been 147 IPOs, up 50% from 2012, and they have delivered an average gain of 36.3%. Foundation (FMI) doubled its first day of trading, Acceleron (XLRN) rose 33% and Premier (PINC) gained 15%. Rocket Fuel (FUEL) doubled on the day it came public and Benefitfocus (BNFT) jumped 102%. FireEye (FEYE) rose 80% on its first day of trading.
Next week, ReMax and Burlington Coat Factory are having their IPOs. Cramer would not get in on either of these deals because real estate might suffer with a possible government shutdown, and apparel has been another weak area. One deal Cramer would get in on is Potbelly Sandwich Works, expected to trade under the symbol (PBPB). It is a fast growing consumer play, is growing its store count by 10% annually and is a regional to national story. Its IPO is expected to price between $9-11, but Cramer would recommend buying it up to $15.
Cramer said the following upcoming IPOs are worth getting in on (the following ticker symbols are the expected symbols): Veracyte (VCYT), Critero (CRTO), Veeva (VEEV), Chegg (CHGG), Voxeljet (VJET), and CommScope (COMM).
Cramer took a call:
Coty (COTY) is going to come under tax loss pressure and doesn't have the growth Cramer wants to see.
CEO Interview: Nigel Travis, Dunkin' Brands (NASDAQ:DNKN)
Dunkin' Brands (DNKN) is a regional to national story that is expanding aggressively. While there are many locations on the East Coast, the company is starting to move into California and Texas. The stock has risen 26% since Cramer recommended it in January and is not done going higher. DNKN has moved beyond breakfast and offers sandwiches for lunch. CEO Nigel Travis says DNKN's afternoon business is growing. The company has 11 million followers on Facebook and communicating with customers has enabled DNKN to develop new products, such as its gluten-free offerings that are currently being tested. "We can do a better job in China," admitted Nigel Travis. Currently, many DNKN stores are going through remodeling, and the number of stores with drive-thru service will be expanded as well as locations that are open later in the day.
2013 was the year of the Permian Basin, and now the next big oil asset in the region is the Delaware Basin. Cimarex (XEC) is a pioneer in the Delaware Basin and has significant assets there. The stock has had a run and is close to its 52 week high, so Cramer would wait for a pullback to buy. The company reported an 11 cent earnings beat with revenues up 39% and production rising 29%. XEC has a strong balance sheet and is small enough to be a possible takeover candidate.
JPMorgan (JPM) is having to pay the government a fine of $11 billion over faulty mortgages. Cramer thinks this could actually be a good thing for the bank, because it may be able to secure an agreement that it won't be fined again for past faulty mortgages. If CEO Jamie Dimon is not dismissed (Cramer thinks he won't be), the stock may have upside when an agreement is reached.
Jim Cramer's Action Alerts PLUS: Trade right alongside a Wall Street pro! Start your 1w4-day FREE trial today.
Get Cramer's Picks by email - it's free and takes only a few seconds to sign up.